Glucagen Injection Market Research Report Information By Application (Therapeutic purpose and Diagnostics purpose), By Age group (Paediatrics and Adults), By Route of Administration (Subcutaneous, Intramuscular and Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL GLUCAGEN INJECTION MARKET, BY APPLICATION

6.1. Overview

6.2. Therapeutic purpose

6.3. Diagnostics purpose

7. GLOBAL GLUCAGEN INJECTION MARKET, BY AGE GROUP

7.1. Overview

7.2. Paediatrics

7.3. Adults

8. GLOBAL GLUCAGEN INJECTION MARKET, BY ROUTE OF ADMINISTRATION

8.1. Overview

8.2. Subcutaneous

8.3. Intramuscular

8.4. Intravenous

9. GLOBAL GLUCAGEN INJECTION MARKET, BY DISTRIBUTION CHANNEL

9.1. Overview

9.2. Hospital Pharmacies

9.3. Retail Pharmacies

9.4. Online Pharmacies

10. GLOBAL GLUCAGEN INJECTION MARKET, BY REGION

10.1. Overview

10.1. North America

10.1.1. US

10.1.2. Canada

10.2. Europe

10.2.1. Germany

10.2.2. France

10.2.3. UK

10.2.4. Italy

10.2.5. Spain

10.2.6. Rest of Europe

10.3. Asia-Pacific

10.3.1. China

10.3.2. India

10.3.3. Japan

10.3.4. South Korea

10.3.5. Australia

10.3.6. Rest of Asia-Pacific

10.4. Rest of the World

10.4.1. Middle East

10.4.2. Africa

10.4.3. Latin America

11. COMPETITIVE LANDSCAPE

11.1. Overview

11.2. Competitive Analysis

11.3. Market Share Analysis

11.4. Major Growth Strategy in the Global Glucagen Injection Market,

11.5. Competitive Benchmarking

11.6. Leading Players in Terms of Number of Developments in the Global Glucagen Injection Market,

11.7. Key developments and Growth Strategies

11.7.1. New Product Launch/Service Deployment

11.7.2. Merger & Acquisitions

11.7.3. Joint Ventures

11.8. Major Players Financial Matrix

11.8.1. Sales & Operating Income, 2022

11.8.2. Major Players R&D Expenditure. 2022

12. COMPANY PROFILES

12.1. Novo Nordisk

12.1.1. Company Overview

12.1.2. Financial Overview

12.1.3. Products Offered

12.1.4. Key Developments

12.1.5. SWOT Analysis

12.1.6. Key Strategies

12.2. Eli Lilly and Company

12.2.1. Company Overview

12.2.2. Financial Overview

12.2.3. Products Offered

12.2.4. Key Developments

12.2.5. SWOT Analysis

12.2.6. Key Strategies

12.3. Xeris Pharmaceuticals

12.3.1. Company Overview

12.3.2. Financial Overview

12.3.3. Products Offered

12.3.4. Key Developments

12.3.5. SWOT Analysis

12.3.6. Key Strategies

12.4. Teva Pharmaceutical Industries

12.4.1. Company Overview

12.4.2. Financial Overview

12.4.3. Products Offered

12.4.4. Key Developments

12.4.5. SWOT Analysis

12.4.6. Key Strategies

12.5. Fresenius SE & Co. KGaA

12.5.1. Company Overview

12.5.2. Financial Overview

12.5.3. Products Offered

12.5.4. Key Developments

12.5.5. SWOT Analysis

12.5.6. Key Strategies

12.6. Xeris Pharmaceuticals Inc

12.6.1. Company Overview

12.6.2. Financial Overview

12.6.3. Products Offered

12.6.4. Key Developments

12.6.5. SWOT Analysis

12.6.6. Key Strategies

12.7. LLC. Zealand Pharma A/S.

12.7.1. Company Overview

12.7.2. Financial Overview

12.7.3. Products Offered

12.7.4. Key Developments

12.7.5. SWOT Analysis

12.7.6. Key Strategies

12.8. AVALON PHARMA PVT. LTD

12.8.1. Company Overview

12.8.2. Financial Overview

12.8.3. Products Offered

12.8.4. Key Developments

12.8.5. SWOT Analysis

12.8.6. Key Strategies

12.9. Sanofi

12.9.1. Company Overview

12.9.2. Financial Overview

12.9.3. Products Offered

12.9.4. Key Developments

12.9.5. SWOT Analysis

12.9.6. Key Strategies

12.10. Roche

12.10.1. Company Overview

12.10.2. Financial Overview

12.10.3. Products Offered

12.10.4. Key Developments

12.10.5. SWOT Analysis

12.10.6. Key Strategies

13. APPENDIX

13.1. References

13.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL GLUCAGEN INJECTION MARKET, SYNOPSIS, 2018-2032

TABLE 2 GLOBAL GLUCAGEN INJECTION MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)

TABLE 3 GLOBAL GLUCAGEN INJECTION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 4 GLOBAL GLUCAGEN INJECTION MARKET, BY AGE GROUP, 2018-2032 (USD BILLION)

TABLE 5 GLOBAL GLUCAGEN INJECTION MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 6 GLOBAL GLUCAGEN INJECTION MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 7 NORTH AMERICA: GLUCAGEN INJECTION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 8 NORTH AMERICA: GLUCAGEN INJECTION MARKET, BY AGE GROUP, 2018-2032 (USD BILLION)

TABLE 9 NORTH AMERICA: GLUCAGEN INJECTION MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 10 NORTH AMERICA: GLUCAGEN INJECTION MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 11 US: GLUCAGEN INJECTION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 12 US: GLUCAGEN INJECTION MARKET, BY AGE GROUP, 2018-2032 (USD BILLION)

TABLE 13 US: GLUCAGEN INJECTION MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 14 US: GLUCAGEN INJECTION MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 15 CANADA: GLUCAGEN INJECTION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 16 CANADA: GLUCAGEN INJECTION MARKET, BY AGE GROUP, 2018-2032 (USD BILLION)

TABLE 17 CANADA: GLUCAGEN INJECTION MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 18 CANADA: GLUCAGEN INJECTION MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 1 EUROPE: GLUCAGEN INJECTION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 2 EUROPE: GLUCAGEN INJECTION MARKET, BY AGE GROUP, 2018-2032 (USD BILLION)

TABLE 3 EUROPE: GLUCAGEN INJECTION MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 4 EUROPE: GLUCAGEN INJECTION MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 5 GERMANY: GLUCAGEN INJECTION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 6 GERMANY: GLUCAGEN INJECTION MARKET, BY AGE GROUP, 2018-2032 (USD BILLION)

TABLE 7 GERMANY: GLUCAGEN INJECTION MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 8 GERMANY: GLUCAGEN INJECTION MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 9 FRANCE: GLUCAGEN INJECTION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 10 FRANCE: GLUCAGEN INJECTION MARKET, BY AGE GROUP, 2018-2032 (USD BILLION)

TABLE 11 FRANCE: GLUCAGEN INJECTION MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 12 FRANCE: GLUCAGEN INJECTION MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 13 ITALY: GLUCAGEN INJECTION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 14 ITALY: GLUCAGEN INJECTION MARKET, BY AGE GROUP, 2018-2032 (USD BILLION)

TABLE 15 ITALY: GLUCAGEN INJECTION MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 16 ITALY: GLUCAGEN INJECTION MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 17 SPAIN: GLUCAGEN INJECTION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 18 SPAIN: GLUCAGEN INJECTION MARKET, BY AGE GROUP, 2018-2032 (USD BILLION)

TABLE 19 SPAIN: GLUCAGEN INJECTION MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 20 SPAIN: GLUCAGEN INJECTION MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 21 UK: GLUCAGEN INJECTION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 22 UK: GLUCAGEN INJECTION MARKET, BY AGE GROUP, 2018-2032 (USD BILLION)

TABLE 23 UK: GLUCAGEN INJECTION MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 24 UK: GLUCAGEN INJECTION MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 25 REST OF EUROPE: GLUCAGEN INJECTION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 26 REST OF EUROPE: GLUCAGEN INJECTION MARKET, BY AGE GROUP, 2018-2032 (USD BILLION)

TABLE 27 REST OF EUROPE: GLUCAGEN INJECTION MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 28 REST OF EUROPE: GLUCAGEN INJECTION MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 29 ASIA-PACIFIC: GLUCAGEN INJECTION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 30 ASIA-PACIFIC: GLUCAGEN INJECTION MARKET, BY AGE GROUP, 2018-2032 (USD BILLION)

TABLE 31 ASIA-PACIFIC: GLUCAGEN INJECTION MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 32 ASIA-PACIFIC: GLUCAGEN INJECTION MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 33 JAPAN: GLUCAGEN INJECTION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 34 JAPAN: GLUCAGEN INJECTION MARKET, BY AGE GROUP, 2018-2032 (USD BILLION)

TABLE 35 JAPAN: GLUCAGEN INJECTION MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 36 JAPAN: GLUCAGEN INJECTION MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 37 CHINA: GLUCAGEN INJECTION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 38 CHINA: GLUCAGEN INJECTION MARKET, BY AGE GROUP, 2018-2032 (USD BILLION)

TABLE 39 CHINA: GLUCAGEN INJECTION MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 40 CHINA: GLUCAGEN INJECTION MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 41 INDIA: GLUCAGEN INJECTION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 42 INDIA: GLUCAGEN INJECTION MARKET, BY AGE GROUP, 2018-2032 (USD BILLION)

TABLE 43 INDIA: GLUCAGEN INJECTION MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 44 INDIA: GLUCAGEN INJECTION MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 45 AUSTRALIA: GLUCAGEN INJECTION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 46 AUSTRALIA: GLUCAGEN INJECTION MARKET, BY AGE GROUP, 2018-2032 (USD BILLION)

TABLE 47 AUSTRALIA: GLUCAGEN INJECTION MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 48 AUSTRALIA: GLUCAGEN INJECTION MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 49 SOUTH KOREA: GLUCAGEN INJECTION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 50 SOUTH KOREA: GLUCAGEN INJECTION MARKET, BY AGE GROUP, 2018-2032 (USD BILLION)

TABLE 51 SOUTH KOREA: GLUCAGEN INJECTION MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 52 SOUTH KOREA: GLUCAGEN INJECTION MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 53 REST OF ASIA-PACIFIC: GLUCAGEN INJECTION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 54 REST OF ASIA-PACIFIC: GLUCAGEN INJECTION MARKET, BY AGE GROUP, 2018-2032 (USD BILLION)

TABLE 55 REST OF ASIA-PACIFIC: GLUCAGEN INJECTION MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 56 REST OF ASIA-PACIFIC: GLUCAGEN INJECTION MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 57 REST OF THE WORLD: GLUCAGEN INJECTION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 58 REST OF THE WORLD: GLUCAGEN INJECTION MARKET, BY AGE GROUP, 2018-2032 (USD BILLION)

TABLE 59 REST OF THE WORLD: GLUCAGEN INJECTION MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 60 REST OF THE WORLD: GLUCAGEN INJECTION MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 61 MIDDLE EAST: GLUCAGEN INJECTION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 62 MIDDLE EAST: GLUCAGEN INJECTION MARKET, BY AGE GROUP, 2018-2032 (USD BILLION)

TABLE 63 MIDDLE EAST: GLUCAGEN INJECTION MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 64 MIDDLE EAST: GLUCAGEN INJECTION MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 65 AFRICA: GLUCAGEN INJECTION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 66 AFRICA: GLUCAGEN INJECTION MARKET, BY AGE GROUP, 2018-2032 (USD BILLION)

TABLE 67 AFRICA: GLUCAGEN INJECTION MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 68 AFRICA: GLUCAGEN INJECTION MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 69 LATIN AMERICA: GLUCAGEN INJECTION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 70 LATIN AMERICA: GLUCAGEN INJECTION MARKET, BY AGE GROUP, 2018-2032 (USD BILLION)

TABLE 71 LATIN AMERICA: GLUCAGEN INJECTION MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 72 LATIN AMERICA: GLUCAGEN INJECTION MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL GLUCAGEN INJECTION MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL GLUCAGEN INJECTION MARKET

FIGURE 4 GLOBAL GLUCAGEN INJECTION MARKET, SHARE (%), BY APPLICATION, 2022

FIGURE 5 GLOBAL GLUCAGEN INJECTION MARKET, SHARE (%), BY AGE GROUP, 2022

FIGURE 6 GLOBAL GLUCAGEN INJECTION MARKET, SHARE (%), BY ROUTE OF ADMINISTRATION, 2022

FIGURE 7 GLOBAL GLUCAGEN INJECTION MARKET, SHARE (%), BY DISTRIBUTION CHANNEL, 2022

FIGURE 8 GLOBAL GLUCAGEN INJECTION MARKET, SHARE (%), BY REGION, 2022

FIGURE 9 NORTH AMERICA: GLUCAGEN INJECTION MARKET, SHARE (%), BY REGION, 2022

FIGURE 10 EUROPE: GLUCAGEN INJECTION MARKET, SHARE (%), BY REGION, 2022

FIGURE 11 ASIA-PACIFIC: GLUCAGEN INJECTION MARKET, SHARE (%), BY REGION, 2022

FIGURE 12 REST OF THE WORLD: GLUCAGEN INJECTION MARKET, SHARE (%), BY REGION, 2022

FIGURE 13 GLOBAL GLUCAGEN INJECTION MARKET: COMPANY SHARE ANALYSIS, 2022 (%)

FIGURE 14 NOVO NORDISK: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 15 NOVO NORDISK: SWOT ANALYSIS

FIGURE 16 ELI LILLY AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 17 ELI LILLY AND COMPANY: SWOT ANALYSIS

FIGURE 18 XERIS PHARMACEUTICALS: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 19 XERIS PHARMACEUTICALS: SWOT ANALYSIS

FIGURE 20 TEVA PHARMACEUTICAL INDUSTRIES: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 21 TEVA PHARMACEUTICAL INDUSTRIES: SWOT ANALYSIS

FIGURE 22 FRESENIUS SE & CO. KGAA.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 23 FRESENIUS SE & CO. KGAA.: SWOT ANALYSIS

FIGURE 24 XERIS PHARMACEUTICALS INC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 25 XERIS PHARMACEUTICALS INC: SWOT ANALYSIS

FIGURE 26 LLC. ZEALAND PHARMA A/S.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 27 LLC. ZEALAND PHARMA A/S.: SWOT ANALYSIS

FIGURE 28 AVALON PHARMA PVT. LTD: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 29 AVALON PHARMA PVT. LTD: SWOT ANALYSIS

FIGURE 30 SANOFI: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 31 SANOFI: SWOT ANALYSIS

FIGURE 32 ROCHE: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 33 ROCHE: SWOT ANALYSIS